SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000891618-03-005917
Filing Date
2003-11-13
Accepted
2003-11-13 16:22:01
Documents
2
Period of Report
2003-11-13
Items
Item 12: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f94460e8vk.htm 8-K 8297
3 EXHIBIT 99.1 f94460exv99w1.htm EX-99.1 61278
  Complete submission text file 0000891618-03-005917.txt   71181
Mailing Address 3832 BAY CENTER PLACE HAYWARD CA 94545
Business Address 3832 BAY CENTER PL HAYWARD CA 94545 5106709300
LYNX THERAPEUTICS INC (Filer) CIK: 0000913275 (see all company filings)

IRS No.: 943161073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22570 | Film No.: 03998414
SIC: 2833 Medicinal Chemicals & Botanical Products